Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)

Circulation

Volumn 100, Issue 8, 1999, Pages 799-806

  Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angioplasty; Glycoproteins; Platelets; Stents; Vitronectin

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; GLYCOPROTEIN; HEPARIN; TICLOPIDINE; VITRONECTIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; THROMBOCYTE;

EID: 0033600547     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.8.799     Document Type: Article

References (35)

1. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the STRESS Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi I, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M-A, for the BENESTENT Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
3. Schwartz RS, Edwards WD, Huber KC, Antoniades LC, Bailey KR, Camrud AR, Jorgenson MA, Holmes DR Jr. Coronary restenosis: prospects for solution and new perspectives from a porcine model. Mayo Clin Proc. 1993;68:54-62.
4. Miller DD, Karim MA, Edwards WD, Schwartz RS. Relationship of vascular thrombosis and inflammatory leukocyte infiltration to neointimal growth following porcine coronary artery stent placement. Atherosclerosis. 1996;124:145-155.
5. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994;24:1591-1601.
6. Matsuno H, Stassen JM, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
7. van der Zee R, Passeri J, Barry JJ, Cheresh DA, Isner JM. A neutralizing antibody to the alpha v beta 3 integrin reduces neointimal thickening in a balloon-injured rabbit iliac artery. Circulation. 1996; 94(suppl I):I-257. Abstract.
8. Wajih N, Sane DC. Mutants of vitronectin at the Arg-Gly-Asp cell recognition sequence have reduced haptotactic capacity for smooth muscle cells. Circulation. 1997;96(suppl I):I-668. Abstract.
9. 3,-mediated vascular smooth muscle cell migration and reduces neointima formation following balloon injury to the rat carotid artery. Circulation. 1997;96(suppl I):I-668. Abstract.
10. 3 antagonist in a rabbit model. Circulation. 1997;96(suppl I):I-668. Abstract.
11. 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994;19:125-134.
12. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Tiell ML, Spaet TH. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. J Clin Invest. 1977;60: 1191-1201.
13. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson JT, on behalf of the EPIC Investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 1994;343:881-886.
14. Simon DI, Xu H, Ortlepp S, Rogers C, Rao NK. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol. 1997;17:528-535.
15. Campbell R, Edelman ER, Simon DI. Blockade of the leukocyte integrin Mac-1 reduces experimental restenosis. Circulation. 1997;96(suppl I):I-667. Abstract.
16. de Jaegere P, Mudra H, Almagor Y, Figulla H, Penn I, Doucet S, Bartorelli A, Hamm C, for the Music Study Investigators. In-hospital and 1-month clinical results of an international study testing the concept of IVUS guided optimized stent expansion alleviating the need of systemic anticoagulation. Presented at the American College of Cardiology Scientific Sessions, Anaheim, Calif, March 26, 1996.
17. Tardif JC, Bilodeau L, Doucet S, Bonan R, Côté G. Comparison between mechanical and phased-array designs for intravascular ultrasound in stented and non-stented coronary arteries: animal studies. Circulation. 1995;92(suppl I):I-600. Abstract.
18. von Birgelen C, Di Mario C, Li W, Schuurbiers JC, Slager CJ, de Feyter PJ, Roelandt JR, Serruys PW. Morphometric analysis in three-dimensional intracoronary ultrasound: an in-vitro and in-vivo study using a novel system for the contour detection of lumen and plaque. Am Heart J. 1996;132:516-527.
19. von Birgelen C, Mintz GS, Nicosia A, Foley DP, van der Giessen WJ, Bruining N, Airiian SG, Roelandt JRTC, de Feyter PJ, Serruys PW. Electrocardiogram-gated intravascular ultrasound image acquisition after coronary stent deployment facilitates on-line three-dimensional reconstruction and automated lumen quantification. J Am Coll Cardiol. 1997; 30:436-443.
20. Li W, von Birgelen C, DiMario C, Boersma E, Gussenhoven EJ, van der Patten N, Bom N. Semi-automatic contour detection for volumetric quantification of intracoronary ultrasound. In: Computers in Cardiology 1994. Los Alamitos, Calif: IEEE Computer Society Press; 1994:277-280.
21. von Birgelen C, de Vrey EA, Mintz GS, Nicosia A, Bruining N, Li W, Slager CJ, Roelandt JRTC, Serruys PW, de Feyter PJ. ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation. 1997;96:2944-2952.
22. Ellis SG, Vandormael MG, Cowley MJ. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation. 1990;82:1193-1202.
23. Popma JJ, Bashore T. Qualitative and quantitative angiography. In: Topol E, ed. Interventional Cardiology. Philadelphia, Pa: WB Saunders; 1993.
24. van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform: basic principles and validation results. J Am Coll Cardiol. 1994;24:216-224.
25. Amman EM, for the TIMI 9a Investigators. Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. Circulation. 1994;90: 1624-1630.
26. 3, integrins. Circulation, 1998; 98:1085-1091.
27. Srivatsa SS, Tsao P, Holmes DR Jr, Schwartz RS, Mousa SA. Temporal and spatial variation in alpha v beta 3 integrin expression following deep arterial injury in the porcine coronary restenosis model. J Am Coll Cardiol. 1997;29:153A. Abstract.
28. Mascelli MA, Lance ET, Damaraju L, Wagner CL, Weisman HF, Jordan RE. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation. 1998;97:1680-1688.
29. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang S-C, Phelps ME, Schelbert HR. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944-1951.
30. Wilson RF, Marcus ML, White CW. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation. 1987;75:723-732.
31. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
32. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94: 1247-1254.
33. Marjinanowski MM, Nakada MT, Sundell BI, Kelly AB, Jordan RE, Jakubowski JA, Chronos NAF, Hanson SR. Abciximab reduces vascular lesion formation in non-human primates. J Am Coll Cardiol. 1999; 33:69A. Abstract.
34. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689-1697.
35. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 1998;352:87-92.